TriSalus Life Sciences announced that its researchers received two JVIR Top Paper Awards for a recent publication, including the JVIR Editor’s Award for Distinguished Laboratory Investigation and the JVIR People’s Choice Award for Most Downloaded Articles. These awards recognize the study titled 'Intra-arterial Pressure-Enabled Drug Delivery™ Significantly Increases Penetration of Glass Microspheres in a Porcine Liver Tumor Model'.
The peer-reviewed study highlighted the superior performance of the TriNav Infusion System in delivering Glass Microspheres into liver tumors when compared to delivery with a traditional microcatheter. The model used a transgenically modified porcine with therapeutic delivery quantified using a machine learning algorithm.
These findings add to the growing body of clinical and real-world evidence supporting the Pressure-Enabled Drug Delivery (PEDD) method's ability to improve the delivery of therapeutic agents for patients with primary and metastatic liver cancers. The awards will be presented at the 2025 Society for Interventional Radiology meeting.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.